Nishikawa H, Osaki Y. Liver cirrhosis: evaluation, nutritional status, and prognosis. Mediators Inflamm. 2015;2015: 872152.
PubMed PubMed Central Google Scholar
National Institutes of Health consensus development conference statement. liver transplantation–June 20–23, 1983. Hepatology. 1984;4:107S-S110.
Calne RY, Rolles K, White DJ, Thiru S, Evans DB, McMaster P, et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet. 1979;2:1033–6.
Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med. 1993;329:1842–7.
Lo CM, Cheung ST, Lai CL, Liu CL, Ng IO, Yuen MF, et al. Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis. Ann Surg. 2001;233:276–81.
CAS PubMed PubMed Central Google Scholar
Marzano A, Salizzoni M, Debernardi-Venon W, Smedile A, Franchello A, Ciancio A, et al. Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis. J Hepatol. 2001;34:903–10.
Yong CC, Chen YS, Wang SH, Lin CC, Liu PP, Liu YW, et al. Deceased-donor liver transplantation: 10 years’ experience at Change Gung memorial hospital Kaohsiung Medical Center. Chang Gung Med J. 2005;28:133–41.
Lin NC, Hsia CY, Loong CC, Liu CS, Tsai HL, Lui WY, et al. Liver transplantation at a small-volume procedure center–preliminary results from Taipei veterans general hospital. J Chin Med Assoc. 2008;71:186–90.
Raia S, Nery JR, Mies S. Liver transplantation from live donors. Lancet. 1989;2:497.
Strong RW, Lynch SV, Ong TH, Matsunami H, Koido Y, Balderson GA. Successful liver transplantation from a living donor to her son. N Engl J Med. 1990;322:1505–7.
Hashikura Y, Makuuchi M, Kawasaki S, Matsunami H, Ikegami T, Nakazawa Y, et al. Successful living-related partial liver transplantation to an adult patient. Lancet. 1994;343:1233–4.
Makuuchi M. Living donor liver transplantation: looking back at my 30 years of experience. Surg Today. 2019;49:288–94.
Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation. 1999;67:321–7.
Sakamoto A, Sakamoto K, Hikida T, Ito C, Iwata M, Shine M, et al. Prolonged warm ischemia time in the recipient is associated with post-transplant biliary stricture following living-donor liver transplantation. Surg Today. 2024;54:1193–200.
Kiuchi T, Tanaka K, Ito T, Oike F, Ogura Y, Fujimoto Y, et al. Small-for-size graft in living donor liver transplantation: how far should we go? Liver Transpl. 2003;9:S29-35.
Francavilla A, Zeng Q, Polimeno L, Carr BI, Sun D, Porter KA, et al. Small-for-size liver transplanted into larger recipient: a model of hepatic regeneration. Hepatology. 1994;19:210–6.
Iida T, Yagi S, Taniguchi K, Hori T, Uemoto S. Improvement of morphological changes after 70% hepatectomy with portocaval shunt: preclinical study in porcine model. J Surg Res. 2007;143:238–46.
Ogura Y, Hori T, El Moghazy WM, Yoshizawa A, Oike F, Mori A, et al. Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before. Liver Transpl. 2010;16:718–28.
Nakayama Y, Li Q, Katsuragawa S, Ikeda R, Hiai Y, Awai K, et al. Automated hepatic volumetry for living related liver transplantation at multisection CT. Radiology. 2006;240:743–8.
Lei HJ, Lin NC, Chen CY, Chou SC, Chung MH, Shyr BU, et al. Safe strategy to initiate total laparoscopic donor right hepatectomy: a stepwise approach from a laparoscopy-assisted method. World J Surg. 2020;44:3108–18.
Ito K, Akamatsu N, Togashi J, Tamura S, Sakamoto Y, Hasegawa K, et al. Outflow reconstruction using cryopreserved homologous venous grafts in living donor liver transplantation. Transplant Proc. 2017;49:109–14.
Hwang S, Jung DH, Ha TY, Ahn CS, Moon DB, Kim KH, et al. Usability of ringed polytetrafluoroethylene grafts for middle hepatic vein reconstruction during living donor liver transplantation. Liver Transpl. 2012;18:955–65.
Yoshizumi T, Mori M. Portal flow modulation in living donor liver transplantation: review with a focus on splenectomy. Surg Today. 2020;50:21–9.
Ikegami T, Shirabe K, Nakagawara H, Yoshizumi T, Toshima T, Soejima Y, et al. Obstructing spontaneous major shunt vessels is mandatory to keep adequate portal inflow in living-donor liver transplantation. Transplantation. 2013;95:1270–7.
Dahm F, Georgiev P, Clavien P-A. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant. 2005;5:2605–10.
Goldaracena N, Echeverri J, Selzner M. Small-for-size syndrome in live donor liver transplantation-Pathways of injury and therapeutic strategies. Clin Transplant. 2017;31: e12885.
Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L, et al. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation. Liver Transpl. 2009;15:1776–82.
Kaido T, Mori A, Ogura Y, Hata K, Yoshizawa A, Iida T, et al. Lower limit of the graft-to-recipient weight ratio can be safely reduced to 0.6% in adult-to-adult living donor liver transplantation in combination with portal pressure control. Transpl Proc. 2011;43:2391–3.
Matsushima H, Soyama A, Hara T, Maruya Y, Fujita T, Imamura H, et al. Outcomes of living donor liver transplant recipients receiving grafts with the graft-to-recipient weight ratio less than 0.6%: a matched pair analysis. Liver Transpl. 2024;30:519–29.
Comments (0)